COH Chicago
COH Chicago
Zion, Illinois, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, transitional cell carcinoma | Recruiting | Phase 1 | 2026-06-18 | NCT07484022 |